Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metformin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02249910
What this trial is testing

Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 32
Large-scale testing (Phase 3)Looking for participantsNCT05532813
What this trial is testing

Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)

Who this might be right for
Steinert's DiseaseMyotonic Dystrophy 1Metformin
Assistance Publique - Hôpitaux de Paris 142
Post-approval studies (Phase 4)Study completedNCT03982381
What this trial is testing

SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Uppsala University 2,067
Post-approval studies (Phase 4)Looking for participantsNCT02915198
What this trial is testing

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Who this might be right for
Prediabetic StateAtherosclerosisMetformin
VA Office of Research and Development 7,410
Testing effectiveness (Phase 2)UnknownNCT02506777
What this trial is testing

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
N.N. Petrov National Medical Research Center of Oncology 96
Post-approval studies (Phase 4)Study completedNCT00624364
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 140
Testing effectiveness (Phase 2)Study completedNCT03088631
What this trial is testing

Metformin in Intracytoplasmic Sperm Injection Cycles

Who this might be right for
Intracytoplasmatic Sperm Injection
Assiut University 320
Testing effectiveness (Phase 2)Study completedNCT05131828
What this trial is testing

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Who this might be right for
Multiple Sclerosis
Cambridge University Hospitals NHS Foundation Trust 70
Early research (Phase 1)Study completedNCT06227832
What this trial is testing

Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants

Who this might be right for
Healthy Adults
Kaken Pharmaceutical 38
Large-scale testing (Phase 3)Study completedNCT01937598
What this trial is testing

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

Who this might be right for
Type 2 Diabetes
Michael A. Nauck 16
Testing effectiveness (Phase 2)Study completedNCT01589367
What this trial is testing

Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of Breast
Seoul National University Hospital 208
Large-scale testing (Phase 3)UnknownNCT03831464
What this trial is testing

Metformin as RenoProtector of Progressive Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Universiteit Antwerpen 290
Large-scale testing (Phase 3)Study completedNCT03054519
What this trial is testing

Improve PAD PERformance With METformin

Who this might be right for
Peripheral Artery Disease
Northwestern University 202
Testing effectiveness (Phase 2)Study completedNCT00423501
What this trial is testing

A GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 306
Large-scale testing (Phase 3)Study completedNCT00627445
What this trial is testing

Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 441
Early research (Phase 1)Study completedNCT04065581
What this trial is testing

Bioequivalence Study for Acarbose/Metformin FDC

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 24
Testing effectiveness (Phase 2)Ended earlyNCT02874430
What this trial is testing

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Who this might be right for
Breast CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Not applicableStudy completedNCT05740345
What this trial is testing

New Approaches to INOCA

Who this might be right for
New Approaches in INOCA
Pasquale Mone 3,000
Not applicableUnknownNCT03961659
What this trial is testing

Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.

Who this might be right for
Type 2 Diabetes MellitusObesityCognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Not applicableEnded earlyNCT06333080
What this trial is testing

The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Aalborg University Hospital 1
Next Page